AdvertisementDrugs For Rare Diseases Have Become Uncommonly Rich Monopolies05:26Download AudioResumeJanuary 17, 2017Sydney LupkinfacebookEmail (Evaluate Pharma analysis for Kaiser Health News on Sept. 21, 2016)